Table 1 Clinicopathological characteristics of NMIBC patients who underwent RC, stratified by PLND and No-PLND.
Variable | Total | No-PLND | PLND | p value |
|---|---|---|---|---|
(n = 544) | (n = 132) | (n = 412) | ||
Median age, yr (IQR) | 69 (63–75) | 69 (64–74) | 69 (63–75) | 0.760 |
Gender, n (%) | 0.942 | |||
Female | 98 (18.0) | 23 (17.4) | 75 (18.2) | |
Male | 446 (82.0) | 109 (82.6) | 337 (81.8) | |
Clinical T-stage, n (%) | 0.593 | |||
cTa | 16 (2.9) | 5 (3.8) | 11 (2.7) | |
cTis | 19 (3.5) | 6 (4.5) | 13 (3.2) | |
cT1 | 509 (93.6) | 121 (91.7) | 388 (94.2) | |
Tumor grade, n (%) | 0.466 | |||
Low | 61 (11.2) | 12 (9.1) | 49 (11.9) | |
High | 483 (88.8) | 120 (90.9) | 363 (88.1) | |
Concomitant CIS, n (%) | 0.439 | |||
Absent | 447 (82.2) | 105 (79.5) | 342 (83.0) | |
Pesent | 97 (17.8) | 27 (20.5) | 70 (17.0) | |
Lymphovascular invasion, n (%) | 0.084 | |||
Absent | 463 (85.1) | 119 (90.2) | 344 (83.5) | |
Present | 81 (14.9) | 13 (9.8) | 68 (16.5) | |
Histological subtypes, n (%) | 0.928 | |||
Absent | 425 (78.1) | 104 (78.8) | 321 (77.9) | |
Present | 119 (21.9) | 28 (21.2) | 91 (22.1) | |
Pathological T-stage, n (%) | 0.017* | |||
pT0 | 44 (8.1) | 6 (4.5) | 38 (9.2) | |
pTa | 3 (0.6) | 1 (0.8) | 2 (0.5) | |
pTis | 32 (5.9) | 8 (6.1) | 24 (5.8) | |
pT1 | 272 (50.0) | 82 (62.1) | 190 (46.1) | |
pT2 | 113 (20.8) | 24 (18.2) | 89 (21.6) | |
pT3 | 61 (11.2) | 6 (4.5) | 55 (13.3) | |
pT4 | 19 (3.5) | 5 (3.8) | 14 (3.4) | |
Median removed lymph nodes (IQR) | - | - | 14 (8–21) | - |
Pathological N-stage, n (%) | - | |||
pN0 | 383 (70.4) | - | 383 (93.0) | |
pN1 | 19 (3.5) | - | 19 (4.6) | |
pN2 | 10 (1.8) | - | 10 (2.4) | |
pNx | 132 (24.3) | 132 (100.0) | - |
